Efalizumab and chest x-ray abnormal Patient Reports February 11, 2012

Efalizumab Side Effects Report #5236597-1
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Jan 26, 2007. Female patient, 68 years of age, weighting 205.5 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: ascites, cardiomegaly, chest x-ray abnormal, clostridium difficile colitis, clostridium difficile sepsis, diverticulum, haematochezia, haemorrhoids, heart rate increased. Efalizumab dosage: 125 MG, 1/WEEK, SUBCUTANEOUS; 1.25ML, 1/WEEK,. During the same period patient was treated with TOPICAL STEROIDS, NORVASC, DETROL LA, LASIX, ACCUPRIL, HYDROCHLOROTHIAZIDE, ACTOS. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4944090-6
Efalizumab side effect was reported by a Physician from UNITED STATES on Feb 24, 2006. Male patient, 43 years of age, weighting 154.3 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, computerised tomogram abnormal, convulsion, electrocardiogram abnormal, full blood count abnormal. Efalizumab dosage: 0.7 MG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4953875-1
Efalizumab side effect was reported by a Physician from UNITED STATES on Mar 08, 2006. Male patient, 43 years of age, weighting 168.0 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, calcinosis, cerebellar ataxia, chest x-ray abnormal, creatine phosphokinase decreased, electrocardiogram t wave abnormal, fall , gait disturbance, grand mal convulsion. Efalizumab dosage: 0.7 MG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4987357-8
Efalizumab side effect was reported by a Physician from UNITED STATES on Apr 10, 2006. Male patient, 43 years of age, weighting 168.0 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, calcinosis, cerebellar ataxia, chest x-ray abnormal, computerised tomogram abnormal, confusional state, dizziness postural, economic problem, electrocardiogram abnormal. Efalizumab dosage: unknown. During the same period patient was treated with DARVOCET. Patient was hospitalized and became disabled. Patient recovered.


Efalizumab Side Effects Report #4992312-8
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Apr 17, 2006. Male patient, 43 years of age, weighting 168.0 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, confusional state, dizziness postural, fall , grand mal convulsion. Efalizumab dosage: 0.7 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with DARVOCET. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4625791-6
Efalizumab side effect was reported by a Physician from on Mar 18, 2005. Female patient, 25 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood culture positive, chest x-ray abnormal, culture tissue specimen positive, haematocrit decreased, haemoglobin decreased, leukocytosis, pyrexia, skin lesion, skin ulcer. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with RINDERON. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4788110-0
Efalizumab side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Sept 26, 2005. Female patient, 25 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, culture positive, exfoliative rash, haematocrit decreased, haemoglobin decreased, leukocytosis, neck pain, pain in extremity, pulmonary vascular disorder. Efalizumab dosage: 1MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with RINDERON. Patient was hospitalized. Patient recovered.